Maybe a simple question, but what is your preferred style for listing DNA length in a publication. Do you use b.p. for double stranded DNA and nt for single stranded DNA or RNA? Then there is the kb vs. knt possibility (if ever?) Is there anywhere where preferred style is found, do some journals have a preference?
-
-
bp/kb is what I have generally seen used. -
Oligo makers describe their ssDNA oligos as 20 bases or nucleotides. I wouldn't use bp for ssDNA. It does raise some fine hair-splitting questions: if you are cloning by restriction digestion, how do you describe the resulting fragment that is dsDNA plus ssDNA overhangs? Most people would describe it as the length between the cut sites, like 374 bp, even though only 370 nucleotides are base paired.Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.comComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment